Recurrence of Thrombotic Thrombocytopenic Purpura after mRNA-1273 COVID-19 Vaccine Administered Shortly after COVID-19
Thrombotic thrombocytopenic purpura (TTP) is a potentially life-threatening consumptive coagulopathy requiring emergent diagnosis and timely treatment. It is characterized by microangiopathic hemolytic anemia and thrombocytopenia with the development of microthrombi caused by inherited or acquired d...
Saved in:
Main Authors: | Korin Karabulut, Ana Andronikashvili, Ahmet Hakki Kapici |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2021/4130138 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19-Induced Fatal Thrombotic Thrombocytopenic Purpura in a Healthy Young Patient
by: Mariana Codevila Buere Pereira, et al.
Published: (2022-01-01) -
Acute myocarditis after the third dose of COVID‐19 mRNA‐1273 vaccine
by: Takayuki Yamada
Published: (2023-05-01) -
Thrombotic Thrombocytopenic Purpura Associated with Pneumococcal Sepsis
by: Jeffrey R Schriber, et al.
Published: (1993-01-01) -
Atypical Thrombotic Thrombocytopenic Purpura Presenting as Stroke
by: Pradeepthi Badugu, et al.
Published: (2019-01-01) -
More on the pathogenesis of thrombotic thrombocytopenic purpura. Comment on “Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism” and on “The different faces of thrombotic thrombocytopenic purpura”
by: Flora Peyvandi
Published: (2025-01-01)